Non-alcoholic fatty liver disease increases the risk of cardiovascular disease in young adults and children: a systematic review and meta-analysis of cohort studies

4Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background and aims: It is uncertain if there is a link between non-alcoholic fatty liver disease (NAFLD) and cardiovascular diseases (CVD) in young adults and children. To evaluate the potential link between these two conditions, we conducted a systematic review and meta-analysis of cohort studies. Methods: A comprehensive search was conducted in PubMed, Web of Science and Embase in order to locate all relevant cohort studies published until August 2023. Random effects meta-analyses were conducted using the generic inverse variance method, with additional subgroup and sensitivity analyses. The Newcastle-Ottawa Scale was employed to evaluate the methodological quality. Results: Four cohort studies (eleven datasets) involving 10,668,189 participants were included in this meta-analysis. This meta-analysis demonstrated that NAFLD increases the risk of CVD in young adults and children (HR = 1.63, 95% CI: 1.46–1.82, P < 0.00001). Further subgroup analyses showed that individuals with NAFLD were at a heightened risk of coronary heart disease (CHD) (HR = 3.10, 95% CI: 2.01–4.77, P < 0.00001), myocardial infarction (MI) (HR = 1.69, 95% CI: 1.61–1.78, P < 0.00001), atrial fibrillation (AF) (HR = 2.00, 95% CI: 1.12–3.57, P = 0.02), congestive heart failure (CHF) (HR = 3.89, 95% CI: 1.20–12.61, P = 0.02), and stroke (HR = 1.47, 95% CI: 1.39–1.55, P < 0.00001). The results of subgroup analyses based on the study location, NAFLD definition, and follow-up time also showed consistency with the overall results. Sensitivity analyses showed that our results were robust. All of the included studies were judged to be of medium to high quality. Conclusion: Current evidence reveals that NAFLD is linked to an increased risk of major CVD (including CHD, MI, AF, CHF and stroke) in young adults and children. Further research is needed to strengthen this association and provide stronger evidence for primary prevention of CVD in young adults and children with NAFLD. Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/, PROSPERO registration number: CRD42023457817.

References Powered by Scopus

Measuring inconsistency in meta-analyses

48629Citations
N/AReaders
Get full text

The PRISMA 2020 statement: An updated guideline for reporting systematic reviews

45898Citations
N/AReaders
Get full text

Bias in meta-analysis detected by a simple, graphical test

42603Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Diet, exercise, and supplements: what is their role in the management of the metabolic dysfunction-associated steatotic liver disease in children?

4Citations
N/AReaders
Get full text

Association of nonalcoholic fatty liver disease with new-onset atrial fibrillation stratified by age groups

1Citations
N/AReaders
Get full text

Prevalence of Transaminitis and Metabolic Dysfunction-Associated Steatotic Liver Disease Among Young Indian Adults—A Population-Based Study

0Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Liao, Y. L., Zhu, G. Y., & Chang, C. (2023). Non-alcoholic fatty liver disease increases the risk of cardiovascular disease in young adults and children: a systematic review and meta-analysis of cohort studies. Frontiers in Cardiovascular Medicine. Frontiers Media SA. https://doi.org/10.3389/fcvm.2023.1291438

Readers' Seniority

Tooltip

Lecturer / Post doc 1

100%

Readers' Discipline

Tooltip

Medicine and Dentistry 3

60%

Nursing and Health Professions 1

20%

Engineering 1

20%

Article Metrics

Tooltip
Mentions
News Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free